People with a complex heart, kidney and metabolic-related condition who got better quality sleep were less likely to have an ...

Too often, patients with chronic kidney disease get diagnosed too late – if at all. Addressing risk factors early can stave ...

Anyone who has diabetes, high blood pressure, heart problems or has a family history of the disease is at increased risk for ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...

In an effort to achieve a target of 80% of patients controlling the three highs and protecting kidney health within eight ...

A research team from the Medical University of Vienna has investigated structural changes in kidneys of patients with ...

March is National Kidney Month – a time to raise awareness and learn more about kidney health and kidney disease. Earlier in ...

Oral semaglutide reduced risk for major adverse CV events by 14% in high-risk adults with type 2 diabetes regardless of SGLT2 ...

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...

While it can affect your body differently when you have diabetes, sugar doesn’t have to be completely off the table.

Injectable semaglutide has better bioavailability, researchers say, but the many patients who want an oral drug are an unmet ...